BHC
Price
$5.30
Change
-$0.37 (-6.53%)
Updated
Apr 4, 04:28 PM (EDT)
Capitalization
3.86B
26 days until earnings call
TKPHF
Price
$31.37
Change
+$0.10 (+0.32%)
Updated
Mar 27 closing price
Capitalization
47.94B
Ad is loading...

BHC vs TKPHF

Header iconBHC vs TKPHF Comparison
Open Charts BHC vs TKPHFBanner chart's image
Bausch Health Companies
Price$5.30
Change-$0.37 (-6.53%)
Volume$900
Capitalization3.86B
Takeda Pharmaceutical
Price$31.37
Change+$0.10 (+0.32%)
Volume$150
Capitalization47.94B
BHC vs TKPHF Comparison Chart
Loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BHC vs. TKPHF commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BHC is a Hold and TKPHF is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (BHC: $5.67 vs. TKPHF: $31.37)
Brand notoriety: BHC: Notable vs. TKPHF: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BHC: 89% vs. TKPHF: 7%
Market capitalization -- BHC: $3.86B vs. TKPHF: $47.94B
BHC [@Pharmaceuticals: Other] is valued at $3.86B. TKPHF’s [@Pharmaceuticals: Other] market capitalization is $47.94B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BHC’s FA Score shows that 1 FA rating(s) are green whileTKPHF’s FA Score has 1 green FA rating(s).

  • BHC’s FA Score: 1 green, 4 red.
  • TKPHF’s FA Score: 1 green, 4 red.
According to our system of comparison, TKPHF is a better buy in the long-term than BHC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BHC’s TA Score shows that 4 TA indicator(s) are bullish.

  • BHC’s TA Score: 4 bullish, 7 bearish.

Price Growth

BHC (@Pharmaceuticals: Other) experienced а -16.00% price change this week, while TKPHF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.78%. For the same industry, the average monthly price growth was -3.83%, and the average quarterly price growth was -11.75%.

Reported Earning Dates

BHC is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.78% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TKPHF($47.9B) has a higher market cap than BHC($3.86B). TKPHF has higher P/E ratio than BHC: TKPHF (22.47) vs BHC (13.39). TKPHF YTD gains are higher at: 17.279 vs. BHC (-29.653). TKPHF has higher annual earnings (EBITDA): 1.15T vs. BHC (2.2B). TKPHF has more cash in the bank: 369B vs. BHC (947M). BHC has less debt than TKPHF: BHC (22.4B) vs TKPHF (4.75T). TKPHF has higher revenues than BHC: TKPHF (4.11T) vs BHC (8.76B).
BHCTKPHFBHC / TKPHF
Capitalization3.86B47.9B8%
EBITDA2.2B1.15T0%
Gain YTD-29.65317.279-172%
P/E Ratio13.3922.4760%
Revenue8.76B4.11T0%
Total Cash947M369B0%
Total Debt22.4B4.75T0%
FUNDAMENTALS RATINGS
BHC vs TKPHF: Fundamental Ratings
BHC
TKPHF
OUTLOOK RATING
1..100
6948
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10085
PRICE GROWTH RATING
1..100
8642
P/E GROWTH RATING
1..100
9746
SEASONALITY SCORE
1..100
n/a30

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TKPHF's Valuation (11) in the null industry is in the same range as BHC (32) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's Profit vs Risk Rating (100) in the null industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's SMR Rating (85) in the null industry is in the same range as BHC (100) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew similarly to BHC’s over the last 12 months.

TKPHF's Price Growth Rating (42) in the null industry is somewhat better than the same rating for BHC (86) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew somewhat faster than BHC’s over the last 12 months.

TKPHF's P/E Growth Rating (46) in the null industry is somewhat better than the same rating for BHC (97) in the Pharmaceuticals Other industry. This means that TKPHF’s stock grew somewhat faster than BHC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BHC
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 12 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VFL10.350.10
+0.93%
abrdn National Municipal Income Fund
SAT24.580.08
+0.33%
Saratoga Investment Corp
EMCR29.11-0.59
-1.99%
Xtrackers EM CarbReduc&ClimtImprvs ETF
QSPT25.78-1.02
-3.80%
FT Vest Nasdaq-100® Buffer ETF Sep
BSVO18.20-1.52
-7.71%
EA Bridgeway Omni Small-Cap Value ETF

TKPHF and

Correlation & Price change

A.I.dvisor tells us that TKPHF and TAK have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TKPHF and TAK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TKPHF
1D Price
Change %
TKPHF100%
N/A
TAK - TKPHF
27%
Poorly correlated
+1.40%
TEVJF - TKPHF
17%
Poorly correlated
-0.34%
ZTS - TKPHF
16%
Poorly correlated
-2.38%
BHC - TKPHF
15%
Poorly correlated
-7.20%
QNTM - TKPHF
13%
Poorly correlated
-2.24%
More